Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01718600 · ClinicalTrials.gov registry record

Long-term Neurocognitive Sequelae of Subclinical Microembolization During Carotid Interventions

A clinical trial of Carotid Artery Stenosis, sponsored by Stanford University.

Completed
Registry status
207
Enrollment target
3
Study locations

NCT01718600: Completed study of Carotid Artery Stenosis, sponsored by Stanford University.

NCT01718600 is a study of Carotid Artery Stenosis that has completed, run by Stanford University. The registered enrollment target is 207 participants, below the 295-participant average among 4 other Carotid Artery Stenosis trials with a reported enrollment target (30% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01718600, a study of Carotid Artery Stenosis, has completed, sponsored by Stanford University.

COMPLETED
Registry status
207 participants
Enrollment target
3
Study locations

Study Summary

Microembolization is commonly associated with carotid artery stenting (CAS), but our understanding of subclinical microembolization is superficial. Through collaborative effects of multidisciplinary team-experts, novel approaches, and longitudinal evaluations, we hope to better understand the clinical significance and long-term cognitive effects of microemboli. This proposal may change our current clinical practice by providing a better outcome measure for carotid interventions and improving outcomes of CAS procedures through risk factor stratification. Our central hypothesis is that development of subclinical microemboli is associated with decline in cognitive function following CAS and that the risk of development of microemboli themselves is associated with patient- and procedure-related factors. We hope that this prospective study will help to clarify these important issues in the era of rapidly evolving percutaneous interventions.

Conditions Studied

Interventions

  • BEHAVIORAL Neuropsychological testing

Study Locations (3)

California

  • Palo Alto Veterans Affairs - Palo Alto

Missouri

  • Washington University School of Medicine - St Louis

Wisconsin

  • University of Wisconsin, Madison - Madison

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2011-06
Est. Completion 2018-04
Stanford University

1,744 total trials

What the finished NCT01718600 record still lists

NCT01718600 is an observational study that tracks outcomes without assigning an intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 295-participant average among 4 other Carotid Artery Stenosis trials with a reported enrollment target (30% lower).

The record links to 1 condition, with Carotid Artery Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Neuropsychological testing is the first listed.

NCT01718600 reports a single indexed study location in California, Missouri, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01718600 about?

NCT01718600 is a clinical study titled "Long-term Neurocognitive Sequelae of Subclinical Microembolization During Carotid Interventions". Microembolization is commonly associated with carotid artery stenting (CAS), but our understanding of subclinical microembolization is superficial. Through collaborative effects of multidisciplinary team-experts, novel approaches, and longitudinal evaluations, we hope to better understand the clinic...

What is the current status of trial NCT01718600?

This trial is currently completed. The enrollment target is 207 participants. The study started on 2011-06. Estimated completion is 2018-04.

What conditions does trial NCT01718600 study?

This clinical trial studies the following conditions: Carotid Artery Stenosis.

What interventions are being tested in trial NCT01718600?

The interventions under investigation include: Neuropsychological testing (BEHAVIORAL).

Who is sponsoring clinical trial NCT01718600?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01718600 being conducted?

This trial has 3 study locations across California, Missouri, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Carotid Artery Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04353778 · 207 participants · Phase 1

    Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

  • NCT05875805 · 207 participants · NA

    A Telehealth Advance Care Planning Intervention

  • NCT06254950 · 207 participants · Phase 2

    A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

  • NCT06904274 · 207 participants · Phase 3

    Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01718600, the US trial registry maintained by the National Library of Medicine. NCT01718600 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.